-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Underperform on Moderna, Raises Price Target to $38

Benzinga·07/07/2026 14:23:02
Listen to the news
B of A Securities analyst Dimple Gosai maintains Moderna (NASDAQ:MRNA) with a Underperform and raises the price target from $34 to $38.